EUVIMEDEUVIMED entdecken
Fall-Kontroll-StudieOpen Access · CC BY 4.0

Antibiotic Use and Later Risk of Celiac Disease: A Nationwide Case-Control and Sibling Analysis

Maria Ulnes, Jonas Söderling, Benjamin Lebwohl, Peter H R Green, Jonas F Ludvigsson, Karl Mårild

Clinical Gastroenterology and Hepatology · 2026-04

DOI: 10.1016/j.cgh.2026.04.009 ↗

Kurz gefasst

Fall-Kontroll-Studie in der Zeitschrift Clinical Gastroenterology and Hepatology, 2026-04. Verfasst von Maria Ulnes und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Region Västra Götaland, Gothenburg, Sw…. Hauptthemen laut MEDLINE: Celiac Disease, Anti-Bacterial Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Karolinska Institutet, Göteborgs Läkaresällskap, Swedish Order of Freemasons Gothenburg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: Antibiotic exposure has, albeit inconsistently, been linked to future celiac disease (CD), but may reflect health care-seeking behavior or treatment of undiagnosed CD. We examined prior antibiotic use in individuals with biopsy-verified CD vs their matched general population comparators and siblings. We also compared associations with individuals with normal mucosa. METHODS: This nationwide Swedish study (2007-2023) assessed antibiotic use up until 1 year before diagnosis/matching in 27,789 individuals with biopsy-verified CD, 133,451 comparators, and 33,112 siblings. Secondary analyses included individuals with histologically normal mucosa (n = 225,548) vs matched comparators (n = 1,089,796). Odds ratios (aORs) were adjusted for comorbidities, socioeconomic status, and health care use. RESULTS: Earlier antibiotic exposure was more common in CD (69%) than in comparators (63%; aOR, 1.24; 95% confidence interval [CI], 1.21-1.28). Restricted analyses to antibiotics ≥5 years before CD diagnosis yielded an aOR of 1.15 (95% CI, 1.11-1.19). The association increased with the number of dispensations (aOR, 1.21; 95% CI, 1.17-1.25 for 1-2; 1.35; 95% CI, 1.30-1.41 for ≥3 vs none). The association between CD and prior antibiotics persisted in sibling comparisons (any use: aOR, 1.29; 95% CI, 1.24-1.35). An even stronger association with antibiotics was seen among individuals with normal mucosa (aOR, 1.50; 95% CI, 1.48-1.51), with a particularly elevated risk in those with ≥3 earlier dispensations (aOR, 1.80; 95% CI, 1.78-1.83). CONCLUSIONS: Individuals with CD were more often exposed to antibiotics before diagnosis than their general population comparators. However, an even stronger association with antibiotic use was seen in those with normal mucosa, suggesting that heightened surveillance rather than causality may contribute to the observed patterns. Although antibiotic stewardship remains important, CD concerns should not deter appropriate antibiotic use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Celiac DiseaseAnti-Bacterial AgentsHumansFemaleSwedenMaleCase-Control StudiesSiblingsAdultMiddle AgedAdolescentChildYoung AdultChild, PreschoolAgedRisk Factors

Stichwörter der Autor:innen

AntibioticsCeliac Disease

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Region Västra Götaland, Gothenburg, Sweden; Department of Pediatrics, Queen Silvia Children's Hospital, Sahl…
  • Division of Clinical Epidemiology, Department of Medicine, Karolinska Institutet, Solna, Sweden.
  • Division of Digestive and Liver Diseases, Department of Medicine, Celiac Disease Center, Columbia University College of Physicians and Surgeons, New York, New York; Department of Epidemiology, Mailman School of Public H…
  • Division of Digestive and Liver Diseases, Department of Medicine, Celiac Disease Center, Columbia University College of Physicians and Surgeons, New York, New York.
  • Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna, Sweden; Department of Pediatrics, Örebro University Hospital, Örebro, Sweden; Department of Medicine, Columbia University College of Ph…

Förderung

  • Karolinska Institutet
  • Göteborgs Läkaresällskap
  • Swedish Order of Freemasons Gothenburg
  • Wilhelm och Martina Lundgrens Stiftelser

Zitieren

APA

Ulnes, M., Söderling, J., Lebwohl, B., Green, P. H. R., Ludvigsson, J. F., & Mårild, K. (2026). Antibiotic Use and Later Risk of Celiac Disease: A Nationwide Case-Control and Sibling Analysis. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2026.04.009

Vancouver

Ulnes M, Söderling J, Lebwohl B, Green PHR, Ludvigsson JF, Mårild K. Antibiotic Use and Later Risk of Celiac Disease: A Nationwide Case-Control and Sibling Analysis. Clinical Gastroenterology and Hepatology. 2026. doi:10.1016/j.cgh.2026.04.009

BibTeX
@article{Ulnes2026,
  author = {Ulnes, Maria and Söderling, Jonas and Lebwohl, Benjamin and Green, Peter H R and Ludvigsson, Jonas F and Mårild, Karl},
  title = {Antibiotic Use and Later Risk of Celiac Disease: A Nationwide Case-Control and Sibling Analysis},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2026},
  doi = {10.1016/j.cgh.2026.04.009}
}
Kostenlos starten →